Back to Trades
Skvarka Jan
DirectorCIK 0001838042
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2026
Skvarka Jan, Director, has filed 2 SEC reports (2026), spread across 2 companies, totaling $441.2K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 18 | ZNTL Zentalis Pharmaceuticals, Inc. | Skvarka Jan | Director | Grant | $0 |
| Jun 12 | GLUE Monte Rosa Therapeutics, Inc. | Skvarka Jan | Insider | Award | $441.2K |
2 filings